Predictive Biosciences Company Profile

Predictive Biosciences is a fully-integrated developer of novel molecular diagnostic cancer assays, and a subspecialty, urology-focused provider of anatomic pathology laboratory products and services. Leveraging a portfolio of patented biomarkers and clinical approaches, the company is building a unique portfolio of assays for cancer management, first targeted at bladder and prostate cancer. Predictive Biosciencesâ commercial division, OncoDiagnostic Laboratory (ODL), is a Clinical Laboratory Improvement Act (CLIA)-certified anatomic pathology and molecular diagnostics lab with a national sales force serving urologists and other subspecialty physicians. For additional information, please visit www.predictivebiosci.com.
News Articles
Predictive Biosciences names Pierre Cassigneul as new CEO
Molecular diagnostic cancer assays developer Predictive Biosciences has named Pierre Cassigneul as the company's new chief executive officer (CEO).
Predictive Bio allows Arup to offer its bladder cancer assay
Arup Laboratories agreed to offer Predictive Biosciences' CertNDx Bladder Cancer Assay to its clients, including health care -More-
Epigenomics, Predictive Biosciences sales and marketing update
MDxHealth, Predictive Biosciences sales and marketing update
Predictive Biosciences to Incorporate Next-Generation Sequencing into CertNDx™ Products
Predictive Biosciences today announced the introduction of next-generation sequencing (NGS) into the company’s CertNDx™ bladder cancer tests. The company has d...
Predictive Biosciences Announces Publication of Recurrence Monitoring Clinical Study
Predictive Biosciences, an innovative developer of molecular diagnostic tests, today announced the publication of the Company’s clinical study for the CertNDx™ Bladder Cancer...
Predictive Biosciences führt Prostatakrebstest basierend auf Epigenomics DNA-Methylierungsmarker ein
Das deutsch-amerikanische Krebsdiagnostik-Unternehmen Epigenomics AG (Frankfurt Prime Standard:...
Predictive Biosciences to Present at AACR Annual Meeting and Oak Ridge Conference
Predictive Biosciences, an innovative developer of molecular diagnostic tests, today announced the company will present data at two key scientific conferences this month on...
Drugs and Medications
Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]
Drug Facts
Anhydrous spf 30 [Owen Biosciences, Inc.]
Drug Facts
Anhydrous spf 30 [Owen Biosciences, Inc.]
Drug Facts
Natelle one [Azur Pharma, Inc.]
Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron
Natelle one [Azur Pharma, Inc.]
Natelle®OneRx Prenatal Vitamin & Plant-Based DHA
PubMed Articles
New wrestling rules of anti-inflammatory transrepression by oxysterol receptor LXR revealed.
When life comes to an end: lessons from microbial aging models.
Introduction to Special Issue ECCS'10 in Theory in Biosciences.
Introduction to special issue ECCS'09 in Theory in Biosciences.
Implicit learning increases preference for predictive visual display.
We investigated whether implicit learning in a visual search task would influence preferences for visual stimuli. Participants performed a contextual cueing task in which they searched for visual targ...
Clinical Trials
We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...
This project aims to validate a predictive model of diabetic retinopathy progression to clinically significant macular edema (CSME) needing photocoagulation and/or vision loss. The Coimbra...
Predictive Risk Stratification Through T Variability in ICD Patients Without Pacing Indications
The aim of the study is to assess the negative predictive value of the T amplitude variance as a method for risk stratification for patients with an increased risk for SCD.
Predictive Values of Serotonergic Alterations for Outcome - 2
The purpose of this study is to evaluate the predictive value of serotonergic alterations for outcome.
Phase II Study to Determine Predictive Markers of Response to BMS-734016 (MDX-010)
The purpose of this study is to identify candidate markers predictive of response and/or serious toxicity to BMS-734016 (MDX-010).
Companies
Predictive Biosciences is a fully-integrated developer of novel molecular diagnostic cancer assays, and a subspecialty, urology-focused provider of anatomic pathology laboratory p...
Predictive Biosciences develops novel molecular diagnostic cancer assays and provides molecular pathology services for urology-based practices. Leveraging a portfolio of patented...
Valent BioSciences Corporation
Headquartered in Libertyville, IL, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Company and is the worldwide leader in the development, manufacturing and co...
JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...
DaVinci Biosciences LLC is a privately held company dedicated to advancing therapies that improve the quality of life for individuals suffering from trauma, disease and degenerative disorders. Through...
More Information about "Predictive Biosciences" on BioPortfolio
We have published hundreds of Predictive Biosciences news stories on BioPortfolio along with dozens of Predictive Biosciences Clinical Trials and PubMed Articles about Predictive Biosciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Predictive Biosciences Companies in our database. You can also find out about relevant Predictive Biosciences Drugs and Medications on this site too.